Ruiz-Grande C, Alarcón C, Alcántara A, Castilla C, López Novoa J M, Villanueva-Peñacarrillo M L, Valverde I
Fundación Jiménez Díaz, Madrid, Spain.
Horm Metab Res. 1993 Dec;25(12):612-6. doi: 10.1055/s-2007-1002190.
We have searched for the contribution of the kidney to the catabolism of glucagon-like peptide-1 (7-36)amide or tGLP-1 by analyzing the disappearance of the [125I]tGLP-1 both in vivo, from the plasma of bilaterally nephrectomized (BNX), ureteral-ligated (BUL) and normal rats and in vitro from the perfusate of an isolated rat kidney system. Also, we have measured the degradation of the peptide by the isolated renal tubules. Results from in vivo studies demonstrated that the disappearance half-time (t1/2) of [125I]tGLP-1 was significantly lower in the control than in BUL or BNX rats with the metabolic clearance rate (MCR) being higher in the control than in BUL and BNX group; no difference was found for both parameters between BUL and BNX rats. The urinary excretion of the peptide was negligible. The data from the isolated kidney experiments showed a disappearance of the peptide, which was not due to its spontaneous degradation nor to enzymes released from the kidney to the perfusate. Degradation of the peptide also occurred in the presence of isolated tubules. It was dependent upon the concentration of tubules. This could possibly be due to the action of the brush border-associated peptidases. In conclusion, our results demonstrate that, in the rat, the kidney removes the exogenous tGLP-1 from the peripheral circulation, by a mechanism that involves glomerular filtration and tubular catabolism.
我们通过分析[125I]tGLP-1在双侧肾切除(BNX)、输尿管结扎(BUL)和正常大鼠血浆中的体内消失情况,以及在离体大鼠肾脏系统灌流液中的体外消失情况,来探寻肾脏对胰高血糖素样肽-1(7-36)酰胺或tGLP-1分解代谢的作用。此外,我们还测定了分离的肾小管对该肽的降解情况。体内研究结果表明,[125I]tGLP-1的消失半衰期(t1/2)在对照组中显著低于BUL或BNX大鼠,对照组的代谢清除率(MCR)高于BUL组和BNX组;BUL大鼠和BNX大鼠在这两个参数上均未发现差异。该肽的尿排泄量可忽略不计。离体肾脏实验的数据显示该肽有消失情况,这既不是由于其自发降解,也不是由于从肾脏释放到灌流液中的酶所致。该肽在分离的肾小管存在时也会发生降解。这取决于肾小管的浓度。这可能是由于刷状缘相关肽酶的作用。总之,我们的结果表明,在大鼠中,肾脏通过涉及肾小球滤过和肾小管分解代谢的机制从外周循环中清除外源性tGLP-1。